Topic: Cytogenetics

NxClinical 5.0 webinar - what to expect

We are ringing in the new year with a webinar on what’s new in NxClinical. Sign-up to save your spot!

The 2019 Southern California Regional Molecular and Cytogenetics Meeting

At the latest SoCal region Cytogenetics and Molecular Genetics meeting, there was much discussion over the future direction of genomic variant detection and classification in oncology.

Southern California Regional Cytogenetics & Molecular Genetics Meeting Proves to be Big Success

The Southern California Regional Cytogenetics & Molecular Genetics Meeting last week was a big success. Some of the biggest names in the space attended and were able to provide feedback on the unique cases that were presented, what tools seem to work best, and how they would approach the issue.

Another Successful ACC Conference

Another successful ACC event. The ACC conference is a great way to really connect with the thought leaders in the cytogenetic community. Read this blog to get the conference highlights!

Chatting with Dr. Ingrid Simonic about Consolidation of Multiple Testing Strategies

Recently we spoke with Dr. Ingrid Simonic, Deputy Director, Medical Genetics Laboratories, Cambridge University Hospitals, about the current stage of testing strategies, in particular the workflow at her hospital. She discussed how they perform many tests at the hospital and not necessarily because there are that many patients but that several tests are performed per patient.

The Secret is out - NxClinical 4.1 is here!

We are excited to announce the release of NxClinical 4.1! Our unique software solution for integration of copy number, sequence variants, and allelic changes obtained from microarray and NGS technologies. NxClinical 4.1 allows combined analysis and interpretation of all genomic variants on a single, platform agnostic system.

The inaugural Southern California Regional Clinical Cytogenetics & Molecular Genetics Meeting was a great success!

Over a dozen of Southern California's finest Cytogenesis and Molecular genesis came together to discuss latest developments, share experiences and information, and help overcome challenges. This proved to be a breeding ground for new ideas, collaborations, and learning.

New Case Study on Ambry Genetics' Implementation of NxClinical Software

We recently published a case study on Ambry Genetics’ use of our NxClinical software which has increased efficiency and has allowed Ambry to handle five times the case load without needing to obtain additional resources.

Can we predict baldness?

Largest study of the genetic architecture of male pattern baldness reveals over 200 novel findings as well as a polygenic predictor.

Patent Filed using Nexus Copy Number – for Canine Cancer Diagnosis

Dr. Breen of North Carolina State University has been a long time user of our Nexus Copy Number software and we were pleased to learn of his application of his latest patent: a new, non-invasive method of diagnosing bladder cancer in dogs.